2025 Program
October 2, 2025
Holistic Approach to
ANCA Vasculitis
By the end of this symposium, participants will be able to describe recent discoveries in clinical and translational research and innovations in care for patients with vasculitis, which aims to improve the long term outcomes
Welcome and Opening Remarks
7:50 am
​
Presented by the Symposium Planning Committee
Personalized treatment for Vasculitis
8:00 am
​
Presented by Dr. David Jayne
​
Objective: By the end of this session, participants will be able to identify potential tailored treatment opportunities for the different vasculitides.
Interesting Case #1
9:00 am
​
Presented by Dr. Al Zahra Al Hashmi
​​
Objective: By the end of this session, participants will be able to evaluate the case and determine its implications for their clinical practice.
Interesting Case #2
9:15 am
​
Presented by Dr. Peihsuan Tsai
​​
Objective: By the end of this session, participants will be able to evaluate the case and determine its implications for their clinical practice.
Effects of brain inflammation in ANCA/SLE in pediatric patients
9:30 am
​
Presented by Dr. Simone Appenzeller
​​
Objective: By the end of this session, participants will be able to explain the effect of inflammation on the brain, cognition, and mental health in patients with AAV and SLE.
Break
10:15 am
Successful transition of youth with chronic diseases
10:45 am
​
Presented by Dr. Susan Samuel
​
Objective: By the end of this session, participants will be able to identify and analyze intrinsic and extrinsic barriers to the successful transition of care to adult health care professionals.
Vasculitis Fellows Presentation
11:15 am
​
Presented by Dr. Al-Bandari Al-Hamzah
​
Objective: By the end of this session, participants will be able to evaluate the value of Vasculitis Fellowships and their impact on career development.
Pediatric ANCA kidney transplant experience
11:35 am
​
Presented by Dr. Siobhan Wong
​
Objective: By the end of this session, participants will be able to assess the role of kidney transplantation in managing end-stage renal disease in pediatric AAV patients and identify potential transplant-associated complications.
Lunch
11:55 am
Interesting Case #3
12:45 pm
​Presented by Dr. Haeja Kessler
​
Objective: By the end of this session, participants will be able to evaluate the case and determine its implications for their clinical practice.
Interesting Case #4
1:00 pm
​
Presented by Dr. Jeanine McColl
​​
Objective: By the end of this session, participants will be able to evaluate the case and determine its implications for their clinical practice.
IgA vasculitis – guideline updates
1:15 pm
​
Presented by Dr. Areefa Alladin
​​
Objective: By the end of this session, participants will be able to summarize the key updates in the new guidelines for IgA vasculitis and discuss their clinical relevance.
Break
2:00 pm
Patient and family support at time of new diagnosis of a chronic disease
2:30 pm
​
Presented by Dr. Elisea De Somma
​
Objective: By the end of this session, participants will be able to identify the types of support needed and available for young people and their families facing a new diagnosis of a chronic disease.
Keynote: Mental health in Chronic Disease
3:00 pm
​
Presented by Dr. Andrea Knight
​
Objective: By the end of this talk, participants will be able to explain the bidirectional relationship between chronic disease and mental health.
Closing Remarks
4:00 pm
​
Presented by the Symposium Planning Committee